Currently, my country's pharmaceutical industry is in a critical period of transformation and upgrading. The national policy level attaches great importance to the comprehensive improvement of drug quality and the optimization and integration of the pharmaceutical industry chain, which includes standardized guidance and support for the research and development and production of pharmaceutical excipients. The "Drug Administration Law" and related regulations and policies have increasingly strict standards and regulatory requirements for pharmaceutical excipients. This is not only a challenge to the industry, but also a major opportunity to promote the upgrading of the pharmaceutical excipient industry.

At the same time, with the continuous innovation of modern pharmaceutical technology, the development of new drug delivery technologies such as sustained and controlled release preparations, targeted preparations, and transdermal drug delivery systems has put forward higher performance requirements and more functions for pharmaceutical excipients. demands. How to develop new excipients that are more in line with drug characteristics and human physiological needs, further improve drug efficacy and reduce adverse reactions, has become a core issue that needs to be solved urgently in the industry.

Therefore, the Pharmaceutical Fusion Circle will hold the "Pharmaceutical Excipients Forum" at the same time as the CMC China Expo on August 15-16, 2024. This forum brings together industry experts, scholars, business representatives, etc. to discuss the regulations and policies of pharmaceutical excipients. , the latest research results, development trends, technical bottlenecks and solutions, promote mutual understanding and cooperation by sharing experiences and opinions, and promote innovation and development in the pharmaceutical excipients industry.